101 related articles for article (PubMed ID: 11585625)
1. Experimental allergic myositis in SJL/J mouse. Reappraisal of immune reaction based on changes after single immunization.
Matsubara S; Kitaguchi T; Kawata A; Miyamoto K; Yagi H; Hirai S
J Neuroimmunol; 2001 Oct; 119(2):223-30. PubMed ID: 11585625
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice.
Suzuki F; Nanki T; Imai T; Kikuchi H; Hirohata S; Kohsaka H; Miyasaka N
J Immunol; 2005 Nov; 175(10):6987-96. PubMed ID: 16272359
[TBL] [Abstract][Full Text] [Related]
3. Histological and immunohistological changes of the skeletal muscles in older SJL/J mice.
Nemoto H; Konno S; Nakazora H; Miura H; Kurihara T
Eur Neurol; 2007; 57(1):19-25. PubMed ID: 17108690
[TBL] [Abstract][Full Text] [Related]
4. The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice.
Kobayashi K; Izawa T; Kuwamura M; Yamate J
Exp Toxicol Pathol; 2010 Sep; 62(5):509-17. PubMed ID: 19615872
[TBL] [Abstract][Full Text] [Related]
5. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
[TBL] [Abstract][Full Text] [Related]
6. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation.
Vafiadaki E; Reis A; Keers S; Harrison R; Anderson LV; Raffelsberger T; Ivanova S; Hoger H; Bittner RE; Bushby K; Bashir R
Neuroreport; 2001 Mar; 12(3):625-9. PubMed ID: 11234777
[TBL] [Abstract][Full Text] [Related]
8. Role of regulatory T cells in a new mouse model of experimental autoimmune myositis.
Allenbach Y; Solly S; Grégoire S; Dubourg O; Salomon B; Butler-Browne G; Musset L; Herson S; Klatzmann D; Benveniste O
Am J Pathol; 2009 Mar; 174(3):989-98. PubMed ID: 19218348
[TBL] [Abstract][Full Text] [Related]
9. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP
Am J Pathol; 2008 Mar; 172(3):774-85. PubMed ID: 18276788
[TBL] [Abstract][Full Text] [Related]
10. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
[TBL] [Abstract][Full Text] [Related]
11. Anti-TNF therapy using etanercept suppresses degenerative and inflammatory changes in skeletal muscle of older SJL/J mice.
Nemoto H; Konno S; Sugimoto H; Nakazora H; Nomoto N; Murata M; Kitazono H; Fujioka T
Exp Mol Pathol; 2011 Jun; 90(3):264-70. PubMed ID: 21324312
[TBL] [Abstract][Full Text] [Related]
12. Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.
Gallardo E; de Andrés I; Illa I
J Neuropathol Exp Neurol; 2001 Sep; 60(9):847-55. PubMed ID: 11556541
[TBL] [Abstract][Full Text] [Related]
13. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B.
Bittner RE; Anderson LV; Burkhardt E; Bashir R; Vafiadaki E; Ivanova S; Raffelsberger T; Maerk I; Höger H; Jung M; Karbasiyan M; Storch M; Lassmann H; Moss JA; Davison K; Harrison R; Bushby KM; Reis A
Nat Genet; 1999 Oct; 23(2):141-2. PubMed ID: 10508505
[No Abstract] [Full Text] [Related]
14. Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo.
Ohyanagi N; Ishido M; Suzuki F; Kaneko K; Kubota T; Miyasaka N; Nanki T
Arthritis Rheum; 2009 Oct; 60(10):3118-27. PubMed ID: 19790078
[TBL] [Abstract][Full Text] [Related]
15. Laminin-induced autoimmune myositis in rats.
Nakano J; Yoshimura T; Okita M; Motomura M; Kamei S; Matsuo H; Eguchi K
J Neuropathol Exp Neurol; 2005 Sep; 64(9):790-6. PubMed ID: 16141789
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).
Suzuki N; Aoki M; Hinuma Y; Takahashi T; Onodera Y; Ishigaki A; Kato M; Warita H; Tateyama M; Itoyama Y
Neurosci Res; 2005 May; 52(1):47-60. PubMed ID: 15811552
[TBL] [Abstract][Full Text] [Related]
17. Distinct effects of contraction-induced injury in vivo on four different murine models of dysferlinopathy.
Roche JA; Ru LW; Bloch RJ
J Biomed Biotechnol; 2012; 2012():134031. PubMed ID: 22431915
[TBL] [Abstract][Full Text] [Related]
18. Identification and partial characterization of FRAG-6, a novel interferon-stimulated gene that is expressed in an IRF-1-INDEPENDENT manner.
Silva AM; Bottrel RL; Reis LF
Cytokine; 1999 Nov; 11(11):813-21. PubMed ID: 10547268
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle myosin is the autoantigen for experimental autoimmune myositis.
Nemoto H; Bhopale MK; Constantinescu CS; Schotland D; Rostami A
Exp Mol Pathol; 2003 Jun; 74(3):238-43. PubMed ID: 12782010
[TBL] [Abstract][Full Text] [Related]
20. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study.
Confalonieri P; Oliva L; Andreetta F; Lorenzoni R; Dassi P; Mariani E; Morandi L; Mora M; Cornelio F; Mantegazza R
J Neuroimmunol; 2003 Sep; 142(1-2):130-6. PubMed ID: 14512171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
